ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Recurrence"

  • 2017 American Transplant Congress

    Effects of the Gut-Liver Axis on Ischemia-Mediated Hepatocellular Carcinoma Recurrence in the Mouse Liver.

    L. Orci,1 S. Lacotte,1 V. Delaune,1 G. Oldani,1 F. Slits,1 C. Rossetti,2 L. Rubbia-Brandt,3 P. Morel,1 C. Toso.1

    1Hepato-pancreato-biliary Centre, Department of Surgery, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland; 2Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, Varese, Italy; 3Division of Clinical Pathology, Department of Pathology and Immunology, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

    Background: There is growing evidence that liver graft ischemia-reperfusion (I/R) is a risk factor for hepatocellular carcinoma (HCC) recurrence after liver transplantation, but the involved…
  • 2017 American Transplant Congress

    Allograft Crescent Predicts Graft Failure in Recurrent IgA Nephropathy Patients.

    S. Park, H. Cho, M.-Y. Yu, Y. Kim, K. Moon, Y. Kim, H. Lee.

    Seoul National University Hospital, Seoul, Korea

    Background A recent multicenter study demonstrates predictive value of crescents in native IgA nephropathy (IgAN), however it remains unclear whether allograft crescent is associated with…
  • 2017 American Transplant Congress

    Outcome and Risk Factors of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.

    G. Chen, C. Wang, Z. Wu, J. Zhang, S. Yu, C. Wang, J. Qiu, L. Chen.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    Background Recurrent focal segmental glomerulosclerosis(FSGS) is common after kidney transplantation . We conducted a retrospective cohort study with the aim to investigating the long-term outcome…
  • 2017 American Transplant Congress

    Predictive Value of Serum Biomarkers of Autoimmunity for Recurrence of IgA Nephropathy After Kidney Transplantation.

    N. Maillard,1 H. Suzuki,2 H. Mohey,1 C. Mariat,1 J. Novak,3 B. Julian,4 F. Berthoux.1

    1Nephrology, Dialysis and Renal Transplantation, CHU Saint Etienne, Saint Etienne, France; 2Division of Nephrology, Department of Internal Medicine, Juntendo University, Tokyo, Japan; 3Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL; 4Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

    The recurrence of IgA nephropathy (IgAN) after kidney transplantation is frequent and can cause graft losses. The prediction of the recurrence cannot be performed from…
  • 2017 American Transplant Congress

    Graft Loss from Anti-GBM Nephritis: A Rare Event in Alport Syndrome, Even with a Severe COL4A5/A4/A3 Mutation.

    V. Gillion,1 K. Dahan,2 E. Goffin,1 J.-P. Cosyns,3 M. Jadoul,1 M. De Meyer,4 M. Mourad,4 Y. Pirson,1 N. Kanaan.1

    1Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2Génétique Humaine, Institut de Pathologie et de Génetique, Gosselies, Belgium; 3Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 4Surgery and Abdominal Transplantation, Cliniques Universitaires Saint-Luc, Brussels, Belgium

    Background: Alport syndrome (AS) is caused by mutations in α3/α4/α5 (IV) collagen genes, whose severity determines the progression of AS. Post-transplant outcome is good, though…
  • 2017 American Transplant Congress

    Recurrent Lupus Nephritis in a Multi-Ethnic Kidney Transplant Population.

    I. Tang,1 A. Koganti,1 S. Setty,2 S. Akkina.3

    1Medicine, University of Illinois at Chicago, Chicago, IL; 2Pahology, University of Illinois at Chicago, Chicago, IL; 3Medicine, Loyola University, Chicago, IL

    The incidence of recurrent lupus nephritis varies among different ethnic groups. We performed a single center retrospective analysis of recurrent lupus nephritis in kidney transplant…
  • 2016 American Transplant Congress

    Recurrence of FSGS Post Kidney Transplantation: Salvage Therapy with ACTHAR® Gel.

    P. Vaitla, D. Daswatta, A. Guasch.

    Transplant, Emory University, Atlanta, GA.

    Recurrence of FSGS post kidney transplantation: Salvage therapy with ACTHAR® gel.Introduction:Recurrence of FSGS post kidney transplantation may reach 25-50%. Failure of treatment or incomplete remission…
  • 2016 American Transplant Congress

    Lower Renal Graft Function and Accelerated Fibrosis in HIV-Infected Transplant Recipients with Previous HIVAN Compared to Non HIVAN HIV-Positive Transplant Recipients.

    M.-N. Peraldi,1 H. Ayari,1 M. Burbach,1 C. Randoux,2 E. Pillebout,1 N. De Castro,3 J.-M. Molina,3 D. Glotz.1

    1Nephrologie et Transplantation, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France; 2Néphrologie, Hôpital Bichat et Université Paris-Diderot, Paris, France; 3Service de Maladies Infectieuses, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France.

    Several studies reported reduced renal allograft survival rates among HIV-infected transplant recipients. Few data focus on histological lesions and their progression in renal grafts from…
  • 2016 American Transplant Congress

    Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

    A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

    Baylor University Medical Center, Dallas, TX.

    IntroductionAutotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can…
  • 2016 American Transplant Congress

    Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.

    D. Aufhauser Jr,1 E. Sadot,2 D. Murken,1 K. Eddinger,1 D. Goldberg,3 E. Furth,4 P. Abt,1 R. DeMatteo,2 M. Levine.1

    1Surgery, University of Pennsylvania, Philadelphia, PA; 2Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; 3Medicine, University of Pennsylvania, Philadelphia, PA; 4Pathology, University of Pennsylvania, Philadelphia, PA.

    Introduction: Resection of hepatocellular carcinoma (HCC) is associated with high rates of intrahepatic recurrence. However, it is unclear whether recurrence results from occult multifocal disease…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences